XTRA:SRT3Life Sciences
Sartorius (XTRA:SRT3) Valuation Check After Q1 2026 Earnings And Confirmed Full Year Guidance
Q1 2026 earnings set the tone for Sartorius
Sartorius (XTRA:SRT3) has put its recent Q1 2026 earnings in focus, reporting sales of €899.1 million and net income of €56.2 million. The company also confirmed its full year guidance and provided commentary on operational momentum.
See our latest analysis for Sartorius.
The latest Q1 update and recent conference presence have not yet translated into sustained share price strength. A 30 day share price return of 4.98% compares with a 12.39% decline...